Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-08-09
2011-08-09
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C264S492000, C264S212000
Reexamination Certificate
active
07993674
ABSTRACT:
Disclosed is a novel solid dosage unit, preferably in the form of a film or thin troche, containing at least one pharmaceutical agent, and its method of manufacture, which involves introduction of a fluid containing at least one non-volatile material, such as a polymeric film forming substance, a volatile carrier and at least one pharmaceutical agent into a depression or cavity comprising the major element of the packaging film for the finished dosage unit (s), and removing the volatile carrier from the cavity by exposure to radiant energy, whereby the remaining non-volatile residue comprises the desired dosage unit. The packaging film can be subsequently lidded by conventional sealing methods to produce packaged dosage units which are suitable for sublingual and other oral applications.
REFERENCES:
patent: 2816666 (1957-12-01), Nadel
patent: 3054503 (1962-09-01), Hartman, Jr. et al.
patent: 3503493 (1970-03-01), Nagy
patent: 4136145 (1979-01-01), Fuchs et al.
patent: 4158411 (1979-06-01), Hall et al.
patent: 4305502 (1981-12-01), Gregory et al.
patent: 4371516 (1983-02-01), Gregory et al.
patent: 4552751 (1985-11-01), Inaba et al.
patent: 4574954 (1986-03-01), Reid
patent: 4713239 (1987-12-01), Babaian et al.
patent: 5009894 (1991-04-01), Hsiao
patent: 5046618 (1991-09-01), Wood
patent: 5229164 (1993-07-01), Pins et al.
patent: 5343672 (1994-09-01), Kearney et al.
patent: 5458879 (1995-10-01), Singh et al.
patent: 5486390 (1996-01-01), Burns et al.
patent: 5516530 (1996-05-01), Lo et al.
patent: 5631023 (1997-05-01), Kearney et al.
patent: 5648093 (1997-07-01), Gole et al.
patent: 5729958 (1998-03-01), Kearney et al.
patent: 5738875 (1998-04-01), Yarwood et al.
patent: 5763476 (1998-06-01), Delbressine et al.
patent: 5820820 (1998-10-01), Pierce
patent: 5837287 (1998-11-01), Yarwood et al.
patent: 5853758 (1998-12-01), Lo
patent: 5866163 (1999-02-01), Myers et al.
patent: 6083531 (2000-07-01), Humbert-Droz et al.
patent: 6155423 (2000-12-01), Katzner et al.
patent: 6193999 (2001-02-01), Gennadios
patent: 6482516 (2002-11-01), Sadek et al.
patent: 7101567 (2006-09-01), Sano et al.
patent: 2002/0184969 (2002-12-01), Kodas et al.
patent: 2003/0107149 (2003-06-01), Yang et al.
patent: 2006/0073188 (2006-04-01), Goutay et al.
patent: 0651997 (1998-10-01), None
patent: 2111423 (1983-07-01), None
patent: WO 95/20377 (1995-08-01), None
patent: WO 95/34290 (1995-12-01), None
patent: WO 97/38679 (1997-10-01), None
patent: WO 01/12161 (2001-02-01), None
The Refractance Window™ Drying Concept : A scientific material explaining the types of refractance window drying concept.
Dann Dorfman Herrell and Skillman, P.C.
Ebrahim Nabila
Hagan Patrick J.
Hartley Michael G
LandOfFree
Drug dose-form and method of manufacture does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Drug dose-form and method of manufacture, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug dose-form and method of manufacture will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2749712